DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
Provided By GlobeNewswire
Last update: May 5, 2025
Châtillon, France, May 5, 2025
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Wednesday, May 7, 2025, at 11:00am ET, in New York, NY.
Read more at globenewswire.comNASDAQ:DBVT (6/9/2025, 11:28:21 AM)
9.03
-0.1 (-1.1%)
Find more stocks in the Stock Screener
DBVT Latest News and Analysis
20 days ago - ChartmillTop movers in Tuesday's sessionWondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
